Literature DB >> 10798157

Pulmonary manifestations of pediatric HIV infection.

M D Khare1, M Sharland.   

Abstract

Vertically acquired HIV infection is becoming increasingly common in India. The main clinical manifestations of HIV in childhood are growth failure, lymphadenopathy, chronic cough and fever, recurrent pulmonary infections, and persistent diarrhoea. Pulmonary disease is the major cause of morbidity and mortality in pediatric AIDS, manifesting itself in more than 80% of cases. The most common causes are Pneumocystis carinii pneumonia (PCP), lymphocytic interstitial pneumonitis (LIP), recurrent bacterial infections which include bacterial pneumonia and tuberculosis. The commonest AIDS diagnosis in infancy is PCP, presenting in infancy with tachypnea, hypoxia, and bilateral opacification on chest-X-ray (CXR). Treatment is with cotrimoxazole. LIP presents with bilateral reticulonodular shadows on CXR. It may be asymptomatic in the earlier stages, but children develop recurrent bacterial super infections, and can progress to bronchiectasis. LIP is a good prognostic sign in children with HIV infection in comparison to PCP. HIV should be considered in children with recurrent bacterial pneumonia, particularly with a prolonged or atypical course, or a recurrence after standard treatment. Pulmonary TB is common in children with HIV, but little data is available to guide treatment decisions. Much can be done to prevent PCP and bacterial infections with cotrimoxazole prophylaxis and appropriate immunisations, which may reduce hospital admissions and health care costs.

Entities:  

Mesh:

Year:  1999        PMID: 10798157     DOI: 10.1007/BF02723864

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   5.319


  24 in total

1.  Role of flexible bronchoscopy and bronchoalveolar lavage in the diagnosis of pediatric acquired immunodeficiency syndrome-related pulmonary disease.

Authors:  J A Birriel; J A Adams; M A Saldana; K Mavunda; S Goldfinger; D Vernon; B Holzman; R M McKey
Journal:  Pediatrics       Date:  1991-06       Impact factor: 7.124

2.  Nonbronchoscopic bronchoalveolar lavage in ventilated children with acquired immunodeficiency syndrome: a simple and effective diagnostic method for Pneumocystis carinii infection.

Authors:  R Amaro-Galvez; M Rao; D Abadco; R E Kravath; P Steiner
Journal:  Pediatr Infect Dis J       Date:  1991-06       Impact factor: 2.129

3.  Update: acquired immunodeficiency syndrome--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-01-17       Impact factor: 17.586

4.  Pneumocystis carinii pneumonia and primary immune deficiency diseases of infancy and childhood.

Authors:  P D Walzer; M G Schultz; K A Western; J B Robbins
Journal:  J Pediatr       Date:  1973-03       Impact factor: 4.406

5.  Helper T-cell responses in children infected with human immunodeficiency virus type 1.

Authors:  E Roilides; M Clerici; L DePalma; M Rubin; P A Pizzo; G M Shearer
Journal:  J Pediatr       Date:  1991-05       Impact factor: 4.406

Review 6.  Opportunistic infections in pediatric HIV disease.

Authors:  R B Van Dyke
Journal:  Ann N Y Acad Sci       Date:  1993-10-29       Impact factor: 5.691

7.  Pulmonary disease in children with acquired immune deficiency syndrome and AIDS-related complex.

Authors:  A Rubinstein; R Morecki; B Silverman; M Charytan; B Z Krieger; W Andiman; M N Ziprkowski; H Goldman
Journal:  J Pediatr       Date:  1986-04       Impact factor: 4.406

Review 8.  Tuberculosis in children.

Authors:  R F Jacobs; J R Starke
Journal:  Med Clin North Am       Date:  1993-11       Impact factor: 5.456

Review 9.  Pneumocystis carinii infections in HIV-infected children.

Authors:  D Sanders-Laufer; W DeBruin; P J Edelson
Journal:  Pediatr Clin North Am       Date:  1991-02       Impact factor: 3.278

10.  Pneumocystis carinii pneumonia in vertically acquired HIV infection in the British Isles.

Authors:  D M Gibb; C F Davison; F J Holland; S Walters; V Novelli; J Mok
Journal:  Arch Dis Child       Date:  1994-03       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.